Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma-Reference-Cited by-同舟云学术

Expression and pharmacological inhibition of TrkB and EGFR in glioblastoma

Published:2020-08-29 Issue:9 Volume:47 Page:6817-6828
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Pinheiro Kelly V.,Thomaz Amanda,Souza Bárbara Kunzler,Metcalfe Victoria Anne,Freire Natália Hogetop,Brunetto André Tesainer,de Farias Caroline Brunetto,Jaeger Mariane,Bambini Victorio,Smith Christopher G. S.,Shaw Lisa,Roesler Rafael^ORCID

Funder

National Council for Scientific and Technological Development

Coordination for the Improvement of Higher Education Personnel

Children’s Cancer Institute

Clinical Hospital institutional research fund

University of Central Lancashire

InbetweenEars

Brain Tumour North West Research Consortium

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-020-05739-2.pdf

Reference43 articles.

1. Mitsudomi T, Yatabe Y (2010) Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J 277(2):301–308

2. Arteaga CL, Engelman JA (2014) ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics. Cancer Cell 25(3):282–303

3. Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, Barnholtz-Sloan J, Zou L, Vegesna R, Shukla SA, Ciriello G, Yung WK, Zhang W, Sougnez C, Mikkelsen T, Aldape K, Bigner DD, Van Meir EG, Prados M, Sloan A, Black KL, Eschbacher J, Finocchiaro G, Friedman W, Andrews DW, Guha A, Iacocca M, O’Neill BP, Foltz G, Myers J, Weisenberger DJ, Penny R, Kucherlapati R, Perou CM, Hayes DN, Gibbs R, Marra M, Mills GB, Lander E, Spellman P, Wilson R, Sander C, Weinstein J, Meyerson M, Gabriel S, Laird PW, Haussler D, Getz G, Chin L, TCGA Research Network (2013) The somatic genomic landscape of glioblastoma. Cell 155(2):462–477

4. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO, European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canada Clinical Trials Group (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996

5. Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359(5):492–507

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atypical cellular responses mediated by intracellular constitutive active TrkB (NTRK2) kinase domains and a solely intracellular NTRK2-fusion oncogene;Cancer Gene Therapy;2024-07-22

2. Gene Expression of CSF3R/CD114 Is Associated with Poorer Patient Survival in Glioma;International Journal of Molecular Sciences;2024-03-05

3. Tropomyosin receptor kinase B ( TrkB ) signalling: targeted therapy in neurogenic tumours;The Journal of Pathology: Clinical Research;2022-12-19

4. Anoikis resistance in diffuse glioma: The potential therapeutic targets in the future;Frontiers in Oncology;2022-08-15

5. Molecular Characteristics of Thalamic Gliomas in Adults;Journal of Molecular Neuroscience;2021-02-01